The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU ASH 2018 Review: Current Updates in Hematologic Diseases
Avatar

ASH 2018 AML: Deciding Between Standard vs Investigational Therapies & Problems in Evaluating New Therapies, MRD and HCT

By KU ASH 2018 Review: Current Updates in Hematologic Diseases FEATURING Elihu H. Estey
By KU ASH 2018 Review: Current Updates in Hematologic Diseases FEATURING Elihu H. Estey
571 views
March 19, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem
ASH: Current Updates in Hematologic Diseases
22:39

ASH December 2018 - MDS - Top Trials and Key Takeaways

KU ASH 2018 Review: Current Updates in Hematologic Diseases

B. Skikne

147 views
25:14

ASH December 2018 - MPN - Review and Synthesis of Recent Trials

KU ASH 2018 Review: Current Updates in Hematologic Diseases

A. Yacoub

105 views
26:11

ASH 2018 Myeloid Neoplasms - How Recent Trials on Stem Cell Transpla…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

A. Singh

238 views
28:21

ASH December 2018 - Benign Hematolgy - Analysis of Top Trials

KU ASH 2018 Review: Current Updates in Hematologic Diseases

P. Harris

547 views
30:39

ASH December 2018 - CLL and Indolent Lymphoma - Review of Clinical T…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

M. Hoffmann

569 views
21:22

ASH December 2018- Aggressive Lymphomas: Recent Approvals and Promis…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

A. Vallurupalli

150 views
25:51

MM - Overview of Trials Presented at ASH 2018

KU ASH 2018 Review: Current Updates in Hematologic Diseases

A. Abdallah

1.3K views
06:55

ASH December 2018 - Lymphoma- Historical Perspective of CAR-T Cell T…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

F. Locke

210 views
24:51

ASH December 2018- Lymphoma - Efficacy and Safety from ZUMA 1, JULIE…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

F. Locke

380 views
14:52

ASH December 2018 - Lymphoma - Axi-cel as Standard of Care and Relat…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

F. Locke

200 views
03:50

ASH December 2018 - Myeloma - BCMA CAR T Therapy for Refractory Pati…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

F. Locke

242 views
23:37

ASH 2018 AML: Deciding Between Standard vs Investigational Therapies…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

E. Estey

571 views
05:54

ASH December 2018 - MRD in AML - What is the Benefit / Risk Ratio Re…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

E. Estey

197 views
06:26

ASH December 2018 - AML - Allogeneic Hematopoietic Cell Transplantat…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

E. Estey

42 views
14:49

ASH 2018 AML Challenges in Evaluating New Therapies: Understanding t…

KU ASH 2018 Review: Current Updates in Hematologic Diseases

E. Estey

181 views
06:55
KU ASH 2018 Review: Current Updates in Hematologic Diseases

Lymphoma and Myeloma - Cellular Therapy, Efficacy and Safety from Top Tria…

Feat. F. Locke